NEW YORK (GenomeWeb) – Molecular diagnostics firm Great Basin Scientific said today that it has submitted a multiplex test for strains of Staphylococcus to the US Food and Drug Administration for 510(k) clearance.

Great Basin submitted the assay after completion of a clinical trial, and the test is the company's first multiplex panel.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.